VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
LongBio Pharma Files for Hong Kong IPO Under Chapter 18A to Advance Allergy and Autoimmune Biologics Pipeline
LongBio Pharma Files for Hong Kong IPO Under Chapter 18A to Advance Allergy and Autoimmune Biologics Pipeline
CST Updated May 22, 2026 10:02
Share: